Table 3.
Treatment outcomes according to absolute lymphocytosis or neutrophilia
| Treatment outcomes | Absolute lymphocytosis, no. of patients (%) | P‐values† | Absolute neutrophilia, no. of patients (%) | P‐values† | ||
|---|---|---|---|---|---|---|
| No (n = 19) | Yes (n = 19) | No (n = 19) | Yes (n = 19) | |||
| Best response | ||||||
| CR | 5 (26) | 2 (11) | 0.051 | 3 (16) | 4 (21) | 0.051 |
| PR | 7 (37) | 4 (21) | 3 (16) | 8 (42) | ||
| SDz | 7 (37) | 13 (68) | 13 (68) | 7 (37) | ||
| Progression | ||||||
| No | 19 (100) | 14 (74) | 0.046 | 15 (79) | 18 (95) | 0.340 |
| Yes | 0 (0) | 5 (26) | 4 (21) | 1 (5) | ||
| 2‐year TTF | 100% | 70% | 0.021 | 73% | 94% | 0.077 |
†Pearson’s chi‐square or Fisher’s exact test. CR, complete remission; PR, partial remission; SDz, stable disease; TTF, time‐to‐treatment failure.